Business Context and Reporting Period
This Form 6-K filing by Embraer S.A. reports on an Ordinary Meeting of the Board of Directors held on March 14, 2024. The filing details the approval of derivative agreements (equity swaps) intended to support the company's long-term incentive plans and mitigate stock price volatility. The reporting period covers the decision date of March 14, 2024.
Key Financial Metrics and Capital Structure
The filing does not provide standard financial performance metrics such as revenue, profit, cash flow, or debt levels. However, it discloses specific capital structure data as of March 14, 2024:
- Outstanding Shares: 734,632,806
- Treasury Shares: 5,832,238
- Derivative Exposure: 3,290,230 shares (approximately 0.4% of total outstanding shares)
Material Changes and Corporate Actions
The primary material change reported is the authorization of a new financial instrument:
- Instrument: Equity Swap contracts.
- Counterparty: Banco Santander S.A.
- Purpose: To hedge against stock price fluctuations for share-based long-term incentive plans. The company will receive price variations related to its shares and pay a cost of CDI + 0.80% per annum on the notional value.
- Settlement: Exclusively financial; no physical purchase or sale of shares will occur.
- Execution Window: 10 trading sessions or until the counterparty acquires the total number of shares, whichever occurs first.
- Term: 18 months (March 22, 2024, to September 22, 2025).
Guidance, Outlook, and Risks
Management Commentary: The Board of Directors, following a positive recommendation from the Audit, Risks, and Ethics Committee, determined that the company's current financial situation is compatible with these operations. Management asserts the transaction will not impair the company's ability to meet creditor obligations or pay mandatory dividends.
Risks and Contingencies:
- Market Risk: The swap exposes the company to market-to-market (MTM) variations. A margin call mechanism is in place with weekly verification; if the MTM variation is negative by 30% for any counterparty, margin calls will be triggered.
- Trading Limits: Daily participation in the swap execution is capped between a minimum of 1% and a maximum of 25% of daily trading volume.
Outlook: The filing does not provide specific revenue or earnings guidance. The focus is on the structural execution of the hedging program.
Key Facts for Investor Verification
- Verify the impact of the CDI + 0.80% cost on future interest expense or other comprehensive income.
- Monitor the 3,290,230 share exposure (0.4% of float) to ensure it remains within the approved limits.
- Confirm that the financial settlement nature of the swap prevents any dilution or reduction in outstanding share count.
- Review future filings for margin call activity related to the weekly MTM verification process.